Evidence Question
What does direct evidence report when benazepril monotherapy is compared with combination therapy with benazepril and valsartan for incidence of hyperkalemia?
Short answer
In indexed direct evidence at the reported timepoint, no difference was reported for incidence of hyperkalemia.
Why do we say this?
The available direct comparison reported no difference for this outcome at the reported timepoint, but the head-to-head evidence base is limited.
Explore the evidence
Related questions
- What does direct evidence report when benazepril monotherapy is compared with combination therapy with benazepril and valsartan for incidence of hypotension?
- What adverse-event evidence has been reported for combination therapy with benazepril and valsartan and incidence of hyperkalemia?
- What does direct evidence report when combination therapy with benazepril and valsartan is compared with valsartan monotherapy for incidence of hyperkalemia?